Hints and tips:
Related Special Reports
Discussions about a possible strategic partnership foundered over two firms’ competing visions
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
Lawsuit sets up rare public clash between two big Wall Street rivals
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
...Add in a complex ownership structure with multiple share classes, and Endeavor may fare better with the Masters of the Universe sorting it out among themselves in private....
Emerging market specialist profited a year ago from real estate and has bought in again after sell-off
...Google DeepMind has developed a prototype artificial intelligence football tactician in collaboration with Premier League club Liverpool, in the latest push to use the technology to master the ebb and flow...
...O’Leary shows a dedication to the craft that once again makes him Alphaville’s 2023 Swear Master. . . ....
Gramercy’s $552.5mn funding will support pollution cases against BHP and Vale, and 14 carmakers over ‘dieselgate’
...brooke.masters@ft.com Follow Brooke Masters with myFT and on Twitter Letter in response to this article: Precision medicine has different economics at play / From Peter Keeling, Chief Executive Officer...
Rare step comes after Brussels fined US biotech for buying Grail without approval
Money for research will be required but salvation may come from a partnership with GSK
...In doing so, he would generate “the highest return on investment endeavour ever taken up in the pharmaceutical industry”....
Acquisitive California asset manager strikes deal that will expand business in alternatives and retirement plans
Mercer predicts money will flow to non-aligned states that have dodged geopolitical crossfire
...“I was the eldest child, I was expected to take over the family [pharmaceuticals] business, but my father could see that I was a radical Marxist, so he let my younger brother take that on,” he says....
...Smart reads Tough act to follow Morgan Stanley’s soon-to-be chief Ted Pick faces a challenge most Wall Street CEOs would envy, the FT’s Brooke Masters writes: keeping up the winning streak....
...Qatar bets on India’s Ambani Turkey’s IPO renaissance Multi-manager hedge funds meet their maker Three decades ago, when star traders such as George Soros, Julian Robertson and Paul Tudor Jones were masters...
...Hm . . . how did that Audre Lorde quote about the master’s tools go?...
Proxy adviser says the two executives failed to take responsibility for destructive deal for Grail
World’s biggest gene sequencing group closed deal with cancer screening start-up despite ongoing investigation
Antitrust challenge may force big pharma groups to rethink ‘pure play’ business models
US gene sequencing company proceeded with acquisition of cancer test developer even as regulators were probing deal
Illumina-owned cancer testing group allegedly failed to deal with accusations of inappropriate behaviour and racism
...BF Borgers’ client list spans far and wide, including several tiny Chinese companies that seem to specialise in everything from pharmaceuticals to vaping....
International Edition